Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell lymphoma responders, a rising risk over time?
2025 · Leukemia · 11 citations
https://doi.org/10.1038/s41375-025-02605-7
H
Hervé Ghesquières
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
49
Citations
3
h-index
2
i10-index
Hervé Ghesquières is an academic researcher from Université Claude Bernard Lyon 1. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Genetic Associations and Epidemiology & Lung Cancer Treatments and Mutations. The author has an h-index of 3, co-authored 6 publications.
Papers by this author
worksAre oldest old patients with diffuse large B-cell lymphoma different than their younger counterparts: Results from the REALYSA real-life cohort
2025 · Cancer Epidemiology · 2 citations
https://doi.org/10.1016/j.canep.2025.102812
Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials
2025 · Blood Cancer Journal · 2 citations
https://doi.org/10.1038/s41408-025-01374-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat